β-Blockers in Stage B: A Precursor of Heart Failure

Mohammad Sarraf, Gary S. Francis

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

β-blockers are an important treatment of heart failure (HF) and are useful in reducing the progression of the syndrome. They should be considered for patients with asymptomatic left ventricular (LV) dysfunction. Evidence-based β-blocker therapy (bisoprolol, carvedilol, or metoprolol succinate) in combination with standard therapy is a mainstay of treatment of all symptomatic patients with LV systolic dysfunction. Patients in stage B also benefit from the early introduction of β-blockers, but there are no large randomized clinical trials to support this strategy. Whether there is a role for ivabradine in the treatment of HF is not clear.

Original languageEnglish (US)
Pages (from-to)237-245
Number of pages9
JournalHeart Failure Clinics
Volume8
Issue number2
DOIs
StatePublished - Apr 2012

Bibliographical note

Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.

Keywords

  • Heart failure
  • Left ventricle
  • Stage B
  • β-blockers

Fingerprint Dive into the research topics of 'β-Blockers in Stage B: A Precursor of Heart Failure'. Together they form a unique fingerprint.

Cite this